Semnur Pharmaceuticals, Inc. Basic Shares Outstanding (Weighted Average)
Semnur Pharmaceuticals, Inc. (SMNR) reported Basic Shares Outstanding (Weighted Average) of 230.21 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-10
- Semnur Pharmaceuticals, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 230.21M shares, a 15.10% increase year-over-year.
- Semnur Pharmaceuticals, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 230.21M shares, a 15.10% increase year-over-year.
- Semnur Pharmaceuticals, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 217.43M shares, a 8.72% increase year-over-year.
- Semnur Pharmaceuticals, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 201.69M shares, a 0.84% increase year-over-year.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | 230.21M shares 10-Q · filed 2026-08-10 | 230.21M shares 10-Q · filed 2026-08-10 | 225.95M shares derived: average of 3 quarters · filed 2026-08-10 | 219.88M shares derived: average of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | 230.21M shares 10-Q · filed 2026-05-13 | 223.82M shares derived: average of 2 quarters · filed 2026-05-13 | 216.44M shares derived: average of 3 quarters · filed 2026-05-13 | 212.33M shares derived: average of 4 quarters · filed 2026-08-10 |
| 2025-12-31 | 217.43M shares derived: S-1 12 month − 10-Q 9 month · filed 2026-05-12 | 209.56M shares derived: average of 2 quarters · filed 2026-05-12 | 206.37M shares derived: average of 3 quarters · filed 2026-08-10 | 204.78M shares S-1 · filed 2026-05-12 |
| 2025-09-30 | 201.69M shares 10-Q · filed 2025-11-12 | 200.84M shares derived: average of 2 quarters · filed 2026-08-10 | 200.57M shares 10-Q · filed 2025-11-12 | 200.42M shares derived: average of 4 quarters · filed 2026-08-10 |
| 2025-06-30 | 200.00M shares 10-Q · filed 2026-08-10 | 200.00M shares 10-Q · filed 2026-08-10 | 200.00M shares derived: average of 3 quarters · filed 2026-08-10 | 200.00M shares derived: average of 4 quarters · filed 2026-08-10 |
| 2025-03-31 | 200.00M shares 10-Q · filed 2026-05-13 | 200.00M shares derived: average of 2 quarters · filed 2026-05-13 | 200.00M shares derived: average of 3 quarters · filed 2026-05-13 | |
| 2024-12-31 | 200.00M shares derived: S-1 12 month − 10-Q 9 month · filed 2026-05-12 | 200.00M shares derived: average of 2 quarters · filed 2026-05-12 | 200.00M shares S-1 · filed 2026-05-12 | |
| 2024-09-30 | 200.00M shares 10-Q · filed 2025-11-12 | 200.00M shares 10-Q · filed 2025-11-12 |